CooperSurgical's KOH colpotomiser system cleared by FDA:
This article was originally published in Clinica
Executive Summary
CooperSurgical's KOH colpotomiser system that allows laparoscopic hysterectomy surgery has been cleared by the FDA for marketing in the US. The system is a new component of the company's RUMI uterine manipulator. CooperSurgical, based in Shelton, Connecticut, estimates that nearly 650,000 hysterectomies are performed in the US annually.
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.